{"id":2283,"date":"2023-01-31T14:49:34","date_gmt":"2023-01-31T13:49:34","guid":{"rendered":"http:\/\/invivo.partners\/?post_type=equipo&#038;p=2283"},"modified":"2025-10-16T16:21:22","modified_gmt":"2025-10-16T14:21:22","slug":"claudio-santos-2","status":"publish","type":"equipo","link":"https:\/\/invivo.partners\/ca\/equipo\/claudio-santos-2\/","title":{"rendered":"Claudio Santos"},"content":{"rendered":"<p>Llicenciat en Biologia (Universitat de Coimbra) i Doctor en Microbiologia i Gen\u00e8tica (Universitat de Salamanca).<\/br><\/br><\/p>\n<p>Director Executiu de Gyala Therapeutics i Pulmobiotics (des del 2020), on dirigeix les operacions, l&#8217;estrat\u00e8gia i les activitats de desenvolupament de negoci i contribueix al pla de desenvolupament cient\u00edfic de les empreses; va treballar amb els fundadors i l\u2019inversor Invivo Partners per crear les empreses, recaptar 3,5 milions d\u2019euros a capital i 5,5 milions d\u2019euros en finan\u00e7ament no dilutiu.<\/br><\/br><\/p>\n<p>Anteriorment, va treballar com a consultor independent per a empreses biotecnol\u00f2giques i fons de capital risc, com Chief Business Officer a Highlight Therapeutics i Director de Planificaci\u00f3 Estrat\u00e8gica a AdorX Therapeutics (va signar una col\u00b7laboraci\u00f3 estrat\u00e8gica amb J&amp;J el 2019).<\/br><\/br><\/p>\n<p>Va passar 3 anys com a Investment Associate al CRT Pioneer Fund (gestionat per Sixth Element Capital, Regne Unit), on va dirigir inversions a Achilles Therapeutics, Artios Pharma, Neophore Ltd i el \u00abPrograma d\u2019inhibici\u00f3 de Ras\u00bb (en col\u00b7laboraci\u00f3 amb Novartis).<\/br><\/br><\/p>\n<p>Gestor de transfer\u00e8ncia de tecnologia a Cancer Research Technology, contribuint a acords de llic\u00e8ncia amb MSD (un acord per valor de fins a 500 milions de d\u00f2lars) i BioInvent AB.<\/br><\/br><\/p>\n<p>Set anys d&#8217;experi\u00e8ncia com a cient\u00edfic postdoctoral al London Research Institute, publicant els seus treballs a NEJM, Nature Genetics, Cancer Discovery i Cell Metabolism.<\/p>\n","protected":false},"template":"","class_list":["post-2283","equipo","type-equipo","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Claudio Santos - Invivo Partners<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/invivo.partners\/ca\/equipo\/claudio-santos-2\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Claudio Santos - Invivo Partners\" \/>\n<meta property=\"og:description\" content=\"Llicenciat en Biologia (Universitat de Coimbra) i Doctor en Microbiologia i Gen\u00e8tica (Universitat de Salamanca). Director Executiu de Gyala Therapeutics i Pulmobiotics (des del 2020), on dirigeix les operacions, l&#8217;estrat\u00e8gia i les activitats de desenvolupament de negoci i contribueix al pla de desenvolupament cient\u00edfic de les empreses; va treballar amb els fundadors i l\u2019inversor Invivo\" \/>\n<meta property=\"og:url\" content=\"https:\/\/invivo.partners\/ca\/equipo\/claudio-santos-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Invivo Partners\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-16T14:21:22+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/invivo.partners\/ca\/equipo\/claudio-santos-2\/\",\"url\":\"https:\/\/invivo.partners\/ca\/equipo\/claudio-santos-2\/\",\"name\":\"Claudio Santos - Invivo Partners\",\"isPartOf\":{\"@id\":\"https:\/\/invivo.partners\/#website\"},\"datePublished\":\"2023-01-31T13:49:34+00:00\",\"dateModified\":\"2025-10-16T14:21:22+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/invivo.partners\/ca\/equipo\/claudio-santos-2\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/invivo.partners\/ca\/equipo\/claudio-santos-2\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/invivo.partners\/ca\/equipo\/claudio-santos-2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/invivo.partners\/ca\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Claudio Santos\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/invivo.partners\/#website\",\"url\":\"https:\/\/invivo.partners\/\",\"name\":\"Invivo Capital\",\"description\":\"Somos un fondo de capital riesgo especializado en proyectos early-stage del sector salud.\",\"publisher\":{\"@id\":\"https:\/\/invivo.partners\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/invivo.partners\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/invivo.partners\/#organization\",\"name\":\"Invivo Capital\",\"url\":\"https:\/\/invivo.partners\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/invivo.partners\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg\",\"contentUrl\":\"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg\",\"width\":1200,\"height\":630,\"caption\":\"Invivo Capital\"},\"image\":{\"@id\":\"https:\/\/invivo.partners\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Claudio Santos - Invivo Partners","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/invivo.partners\/ca\/equipo\/claudio-santos-2\/","og_locale":"ca_ES","og_type":"article","og_title":"Claudio Santos - Invivo Partners","og_description":"Llicenciat en Biologia (Universitat de Coimbra) i Doctor en Microbiologia i Gen\u00e8tica (Universitat de Salamanca). Director Executiu de Gyala Therapeutics i Pulmobiotics (des del 2020), on dirigeix les operacions, l&#8217;estrat\u00e8gia i les activitats de desenvolupament de negoci i contribueix al pla de desenvolupament cient\u00edfic de les empreses; va treballar amb els fundadors i l\u2019inversor Invivo","og_url":"https:\/\/invivo.partners\/ca\/equipo\/claudio-santos-2\/","og_site_name":"Invivo Partners","article_modified_time":"2025-10-16T14:21:22+00:00","twitter_card":"summary_large_image","twitter_misc":{"Temps estimat de lectura":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/invivo.partners\/ca\/equipo\/claudio-santos-2\/","url":"https:\/\/invivo.partners\/ca\/equipo\/claudio-santos-2\/","name":"Claudio Santos - Invivo Partners","isPartOf":{"@id":"https:\/\/invivo.partners\/#website"},"datePublished":"2023-01-31T13:49:34+00:00","dateModified":"2025-10-16T14:21:22+00:00","breadcrumb":{"@id":"https:\/\/invivo.partners\/ca\/equipo\/claudio-santos-2\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/invivo.partners\/ca\/equipo\/claudio-santos-2\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/invivo.partners\/ca\/equipo\/claudio-santos-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/invivo.partners\/ca\/"},{"@type":"ListItem","position":2,"name":"Claudio Santos"}]},{"@type":"WebSite","@id":"https:\/\/invivo.partners\/#website","url":"https:\/\/invivo.partners\/","name":"Invivo Capital","description":"Somos un fondo de capital riesgo especializado en proyectos early-stage del sector salud.","publisher":{"@id":"https:\/\/invivo.partners\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/invivo.partners\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/invivo.partners\/#organization","name":"Invivo Capital","url":"https:\/\/invivo.partners\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/invivo.partners\/#\/schema\/logo\/image\/","url":"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg","contentUrl":"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg","width":1200,"height":630,"caption":"Invivo Capital"},"image":{"@id":"https:\/\/invivo.partners\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/equipo\/2283","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/equipo"}],"about":[{"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/types\/equipo"}],"wp:attachment":[{"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/media?parent=2283"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}